| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 479.20M | 402.50M | 405.60M | 378.70M | 616.10M |
| Gross Profit | 426.30M | 244.50M | 343.00M | 305.70M | 540.70M |
| EBITDA | 144.40M | 110.60M | 41.20M | 95.30M | 237.40M |
| Net Income | 100.40M | 65.20M | -12.90M | 47.90M | 149.60M |
Balance Sheet | |||||
| Total Assets | 1.24B | 1.26B | 1.21B | 1.24B | 1.34B |
| Cash, Cash Equivalents and Short-Term Investments | 403.00M | 502.90M | 445.90M | 396.90M | 383.90M |
| Total Debt | 38.70M | 90.80M | 93.80M | 95.80M | 100.40M |
| Total Liabilities | 336.50M | 422.50M | 418.10M | 398.10M | 439.90M |
| Stockholders Equity | 906.10M | 834.00M | 789.50M | 843.30M | 900.80M |
Cash Flow | |||||
| Free Cash Flow | 62.00M | 66.30M | 84.50M | 153.50M | 181.40M |
| Operating Cash Flow | 62.50M | 73.90M | 88.00M | 158.80M | 184.90M |
| Investing Cash Flow | 80.00M | -182.20M | -56.60M | 34.10M | -13.10M |
| Financing Cash Flow | -86.70M | 101.90M | -37.80M | -112.50M | -162.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £623.43M | 5.68 | 30.00% | 8.73% | 7.71% | -7.39% | |
76 Outperform | £8.95B | 11.95 | 12.35% | 5.37% | 4.78% | -4.86% | |
74 Outperform | £846.15M | 8.25 | 11.49% | 2.70% | -4.38% | ― | |
72 Outperform | £219.25M | 13.32 | 7.58% | 5.14% | -13.29% | 63.87% | |
70 Outperform | £2.17B | 17.89 | 4.75% | 4.91% | 14.05% | -3.07% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | £153.18M | 11.47 | 9.72% | 21.31% | -15.65% | -12.27% |